期刊文献+

支气管扩张严重度指数和FACED评分对支气管扩张症预后评估的比较 被引量:16

Comparison between bronchiectasis severity index and FACED score for the prognostic assessment of bronchiectasis
原文传递
导出
摘要 目的:以支气管扩张严重度指数(bronchiectasis severity index,BSI)和 FACED评分两种方法,评估92例支气管扩张患者的临床资料,比较两种评分方法判断支气管扩张症预后情况。方法收集我院呼吸科住院的92例支气管扩张患者,随访1年,对比两种评分系统判断患者预后的敏感性、特异性。结果两种评分系统低危组、中危组患者病死率明显低于高危组,低危、中危和高危组病死率,BSI评分组为2.9%、12.5%和38.9%,FACED评分组为5.6%、10.3%和41.2%,差异有统计学意义。两种评分系统判断支气管扩张症预后的敏感性分别为92.9%和68.4%,特异性分别为89.7%和90.4%,阳性预测值分别为61.9%和65.0%,阴性预测值分别为98.6%和91.7%。结论 BSI和 FACED评分系统均能准确反映支气管扩张患者的病情严重程度和判断预后,BSI 评分敏感性高,阴性预测值高,评分系统相对复杂,适合病房应用。FACED 评分敏感性低,特异性高,阳性预测值高,评分相对简单,适合门诊使用。 Objective Bronchiectasis severity index (BSI) and FACED were used to evaluate the medical records of 92 patients with bronchiectasis at our hospital.The comparisons of BSI and FACED were made to assess bronchiectasis severity with respect to its prognosis.Methods Ninety-two cases with bronchiectasis were chosen.1 year was regarded as the observation terminal and the outcomes as the observation.BSI and FACED were evaluated at the sensitivity,specificity in assessment of condition and prognosis in bronchiectasis.Results The two score systems showed that the mortality of the low-risk or moderate-risk group was significantly lower than high-risk group:2.9% vs 12.5% vs 38.9% for BSI, 5.6% vs 10.3% vs 41.2% for FACED (all P 〈0.05).The sensitivity were 92.9% and 68.4% in bronchieectasis using BSI and FACED,their specificity were 89.7% and 90.4%,respectively.Their positive predictive rates were 61.9% and 65.0%,respectively.Their negative predictive rates were 98.6%and 9 1 .7%,respectively.Conclusions The two score systems can accurately reflect the condition of severity and prognosis in bronchiectasis patients.The sensitivity and negative predictive rates of BSI score are higher and more complicated than FACED.BSI Score is suitable for use in ward.The sensitivity of FACED is lower than BSI,but the specificity and negative predictive rates are higher than BSI.FACED is suitable for use in outpatient department.
出处 《国际呼吸杂志》 2016年第12期926-929,共4页 International Journal of Respiration
关键词 支气管扩张症 评分 严重度 预后 Bronchiectasis Score Severity Prognosis
  • 相关文献

参考文献9

  • 1Martinez-Garcia MA, de Gracia J, Vendrell Relat M, et alMultidimensional approach to non-cystic fibrosis bronchieetasis: the FACED score [J] . Eur Respir J, 2014, 43 (5) : 1357-1367. DOI: 10. 1183/09031936. 00026313.
  • 2Stenton C. The MRC breathlessness scale [J]. Occup Med (Lond), 2008, 58 (3): 226-227. DOI: 10. 1093/occmed/ kqm162.
  • 3Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study[J]. Am J Respir Crit Care Med, 2014, 189 (5) : 576-585. DOI: 10. 1164/rccm. 201309-1575OC.
  • 4Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a iong-term study assessing the factors influencing survival[J]. Eur Respir J, 2009, 34 (4):843-849. DOI : 10. 1183/09031936. 00003709.
  • 5Onen ZP, Gulbay BE, Sen E, et al. Analysis of the factors related to mortality in patients with bronchiectasis[J]. Respir Med, 2007, 101(7):1390-1397. DOI: 10. 1016/j. rmed. 2007. 02. 002.
  • 6焦瑞,刘双.支气管扩张症急性加重的危险因素及意义[J].中华医学杂志,2015,95(4):273-276. 被引量:31
  • 7Minov J, Karadzinska-Bislimovska J, Vasilevska K, et al. Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronehiectasis Severity Index[J]. Open Respir Med J, 2015,9 : 46-51. DOI: 10. 2174/ 1874306401509010046. eCollection 2015.
  • 8马姣,李银鹏,刘政.非囊性纤维化支气管扩张治疗进展[J].国际呼吸杂志,2014,34(24):1890-1894. 被引量:2
  • 9席秀红,毕晶,李涛,杨达伟,卢水华,王桂芳,李倬哲,白春学,宋元林.成人非囊性纤维化性支气管扩张的诊治进展[J].国际呼吸杂志,2014,34(12):953-957. 被引量:4

二级参考文献84

  • 1张永祥,杨秀芬,孙武装,王丽红.支气管扩张症的诊治进展[J].国际呼吸杂志,2006,26(9):717-720. 被引量:35
  • 2Twiss J,Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country [J] Arch Dis Child, 2005,90 : 737-740.
  • 3Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children:causes and clinical courses[J]. Pediatr Pulmonol, 2000,29 : 182-187.
  • 4Wilson CB, Jones PW, O'Leary CJ, et al. Validation of the St. George's Respiratory Questionnaire ir: bronchiectasis[J]. Am J Respir Crit Care Med, 1997,156 : 536-541.
  • 5van der Bruggen-Bogaarts BA, van der Bruggen HM, van Waes PF, et al. Assessment of bronchiectasis: comparison of HRCT and spiral volumetric CT [J]. J Comput Assist Tomogr, 1996,20 : 15-19.
  • 6Bisaecinni C, Ann MV, Ca]uela E, et al. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis,gast':'oesophageal reflux disease, vocal cord dysfunction and bronchiectasis[J]. Clinics (Sao Paulo), 2009,64 : 769-773.
  • 7Ip MS, So SY, Lam WK, et al. High prevalence of asthma in patients with bronchiectasis in Hong Kong[J]. Eur Respir J, 1992,5:418-423.
  • 8Martinez-Garcia MA, de la Rosa Carrillo D, Soler-Catalufia J J, et al. Prognostic value of bronchiectasis in patients with m'oderate-to-severe chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Meal,2013,187:823-831.
  • 9Chang CC: Morris PS, Chang AB, et al. Influenza vaccine for children and adults with bronchiectasis [J ]. Cochrane Database Syst Rev, 2007,3 : CD006218.
  • 10Poole P J, Chacko E, Wood-Baker RW, et al. Influenza vaccine for patients with chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2006,1 : CD002733.

共引文献33

同被引文献162

引证文献16

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部